Χώρα: Νέα Ζηλανδία
Γλώσσα: Αγγλικά
Πηγή: Medsafe (Medicines Safety Authority)
Celecoxib 200mg; ;
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Celecoxib 200 mg
200 mg
Capsule
Active: Celecoxib 200mg Excipient: Croscarmellose sodium Gelatin Lactose monohydrate Magnesium stearate Povidone Sodium laurilsulfate
Blister pack, physican sample pack, 2 capsules
Prescription
Prescription
Pfizer Pharmaceuticals LLC
Symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. For the management of acute pain and treatment of primary dysmenorrhoea in adults. The decision to prescribe a selective COX-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. As the cardiovascular risks of the selective COX-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. Patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.
Package - Contents - Shelf Life: Blister pack, physican sample pack - 2 capsules - 36 months from date of manufacture stored at or below 30°C - Blister pack, physican sample pack - 10 capsules - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Aluminium foil or PVC/Aclar-Aluminium foil - 30 capsules - 36 months from date of manufacture stored at or below 30°C
1998-09-03
CELEBREX ® Page 1 of 4 CELEBREX _CELECOXIB _ _(SELL-E-COX-IB)_ _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Celebrex. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Celebrex against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. READ THIS LEAFLET CAREFULLY BEFORE YOU START CELEBREX AND KEEP IT WITH THE MEDICINE. You may need to read it again. WHAT CELEBREX IS USED FOR Celebrex is used to treat joint pain, tenderness, swelling and stiffness in: • osteoarthritis, • rheumatoid arthritis and • ankylosing spondylitis, a chronic inflammatory rheumatic disorder that primarily affects, but is not limited to, the spine. Celebrex is also used to relieve short- term pain, in cases such as: • menstrual cramps (period pain) • following surgery • dental pain. Celebrex contains celecoxib and belongs to a group of medicines called Coxibs which are used to relieve pain and inflammation in a number of conditions. Although Celebrex can relieve the symptoms of pain and inflammation, it will not cure your condition. Your doctor, however, may have prescribed Celebrex for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY CELEBREX HAS BEEN PRESCRIBED FOR YOU. Celebrex is not approved for use in children or adolescents under 18 years of age. This medicine is only available with a doctor's prescription. BEFORE YOU TAKE IT _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE CELEBREX IF: • YOUR DOCTOR HAS TOLD YOU THAT YOU HAVE SEVERE HEART OR BLOOD VESSEL DISEASE AFFECTING THE CIRCULATION IN YOUR BRAIN OR LIMBS • YOU HAVE SEVERE LIVER PROBLEMS Your doctor will decide if your condition is too severe to take this medicine. • YOU HAVE PROBLEMS WITH YOUR KIDNEY FUNCTION • YOU HAVE HAD AN ATTACK OF ASTHMA, HIVES, I Διαβάστε το πλήρες έγγραφο
CELEBREX – data sheet Page 1 of 35 NEW ZEALAND DATA SHEET 1. PRODUCT NAME Celebrex ® 100 mg and 200 mg capsules. 2. QUALITATIVE AND QUANTITATIVE COMPOISTION Celebrex 100 mg contains 100 mg celecoxib. Celebrex 200 mg contains 200 mg celecoxib. EXCIPIENT(S) WITH KNOWN EFFECT Each 100 mg and 200 mg capsule contains 149.7 mg and 49.8 mg lactose monohydrate, respectively. For the full list of excipients, see section 6.1 List of Excipients. 3. PHARMACEUTICAL FORM 100 mg capsules: Opaque, white capsules with 2 blue bands marked 7767 and 100. 200 mg capsules: Opaque, white capsules with 2 gold bands marked 7767 and 200. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. For the management of acute pain and treatment of primary dysmenorrhoea in adults. The decision to prescribe a selective cyclooxygenase 2 (COX-2) inhibitor should only be made: • if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and • after assessment of the individual patient’s overall risks. As the cardiovascular (CV) risks of the selective COX-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. Patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment. 4.2 DOSE AND METHOD OF ADMINISTRATION DOSE All patients taking celecoxib should commence therapy at the lowest recommended dose, and be titrated to the lowest dose compatible with effective control of symptoms for the shortest possible period. CELEBREX – data sheet Page 2 of 35 Patients on long-term treatment should be reviewed regularly with regards to efficacy, risk factors and ongoing need for treatment. The following doses can be given without regar Διαβάστε το πλήρες έγγραφο